NCT05862779

Brief Summary

To evaluate the effect of omega-3 supplementation combined with whey protein intake on lean mass and strength gains in older adults performing resistance exercise. Participants will be randomized into the 4 groups. The placebo group will receive 4 g per day of corn oil and 40 g per day of maltodextrin. The omega 3 + placebo group will receive 4 g per day of fish oil and 40 g per day of maltodextrin. The whey protein + placebo group will receive 40g per day of whey and 4g per day of corn oil. The omega 3 + whey group will receive 4g per day of fish oil and 40g per day of protein. All will perform the same exercise protocol for 12 weeks

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 17, 2023

Completed
1.2 years until next milestone

Study Start

First participant enrolled

July 30, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

October 16, 2024

Status Verified

October 1, 2024

Enrollment Period

1.3 years

First QC Date

April 10, 2023

Last Update Submit

October 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in lean mass (kg) using ultrasound and electrical bioimpedance in postmenopausal women

    up to 12 weeks

Secondary Outcomes (1)

  • Changes in strength (kg) using dynamometer in postmenopausal women

    up to 12 weeks

Study Arms (4)

Placebo Group

PLACEBO COMPARATOR

Group supplemented with maltodextrin (40g/day) and corn oil (4g/day). All groups will undergo a training program with strength exercises for 12 weeks

Dietary Supplement: Placebo Group

Whey Protein + Placebo

EXPERIMENTAL

Group supplemented with isolated whey protein (40g/day) and corn oil (4g/day). All groups will undergo a training program with strength exercises for 12 weeks.

Dietary Supplement: Whey Protein + Placebo

Omega 3 + Placebo

EXPERIMENTAL

Group supplemented with omega-3 (4g/day) and maltodextrin (40g/day). All groups will undergo a training program with strength exercises for 12 weeks.

Dietary Supplement: Omega 3 + Placebo

Omega 3 + Whey Protein

EXPERIMENTAL

Group supplemented with omega-3 (4g/day) and whey protein (40g/day). All groups will undergo a training program with strength exercises for 12 weeks.

Dietary Supplement: Omega 3 + Whey Protein

Interventions

Placebo GroupDIETARY_SUPPLEMENT

The placebo group will receive 4 g per day of corn oil and 40 g per day of maltodextrin.

Placebo Group
Whey Protein + PlaceboDIETARY_SUPPLEMENT

The whey protein + placebo group will receive 40g per day of whey and 4g per day of corn oil.

Whey Protein + Placebo
Omega 3 + PlaceboDIETARY_SUPPLEMENT

The omega 3 + placebo group will receive 4 g per day of fish oil and 40 g per day of maltodextrin.

Omega 3 + Placebo
Omega 3 + Whey ProteinDIETARY_SUPPLEMENT

The omega 3 + whey group will receive 4g per day of fish oil and 40g per day of protein.

Omega 3 + Whey Protein

Eligibility Criteria

Age60 Years - 85 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal women (at least 1 year of menstrual interruption, self-reported);
  • To be able to practice strength exercises;
  • To be able to carry out supplementation;
  • Do not present physical, orthopedic or cardiovascular complications that prevent the performance of physical exercises;
  • No history of stroke or acute myocardial infarction;
  • Not being a smoker and/or alcoholic;
  • Do not perform hormone replacement therapy;
  • Do not use anti-inflammatory drugs;
  • To have normal kidney function;
  • To submit a medical certificate of health that proves that the individual is able to perform exercises.

You may not qualify if:

  • Do not provide the necessary information for the development of the study;
  • Individuals with diseases previously diagnosed and undergoing treatment, such as type II diabetes mellitus, cancer, rheumatoid arthritis, high blood pressure, dyslipidemia, cardiovascular, and kidney and/or liver diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of Uberlandia

Uberlândia, Minas Gerais, 38400-902, Brazil

RECRUITING

MeSH Terms

Conditions

Sarcopenia

Interventions

Whey ProteinsDocosahexaenoic Acids

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Milk ProteinsAnimal Proteins, DietaryDietary ProteinsProteinsAmino Acids, Peptides, and ProteinsWheyMilkDairy ProductsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesFatty Acids, Omega-3Dietary Fats, UnsaturatedDietary FatsFatsLipidsFatty Acids, UnsaturatedFatty AcidsFish OilsOils

Central Study Contacts

Erick P de Oliveira, PhD

CONTACT

Erick P de Oliveira, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

April 10, 2023

First Posted

May 17, 2023

Study Start

July 30, 2024

Primary Completion

December 1, 2025

Study Completion

May 1, 2026

Last Updated

October 16, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations